B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ibrutinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ibrutinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

zanubrutinib
15 shared targets
acalabrutinib
11 shared targets
masitinib
16 shared targets
saracatinib
20 shared targets
motesanib
18 shared targets
cabozantinib
15 shared targets
tirabrutinib
9 shared targets
ponatinib
22 shared targets
canertinib
29 shared targets
dasatinib
14 shared targets
Loading evidence profile...

This evidence profile for Ibrutinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.